ClinVar Miner

Submissions for variant NM_032861.4(SERAC1):c.440C>T (p.Thr147Met)

gnomAD frequency: 0.00411  dbSNP: rs114443105
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000610930 SCV000729053 benign not specified 2017-03-15 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Invitae RCV000861165 SCV001001403 benign 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 2024-01-22 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000861165 SCV002554881 benign 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 2022-03-15 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000861165 SCV002796018 likely benign 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 2021-10-08 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV003432648 SCV004156335 benign not provided 2023-04-01 criteria provided, single submitter clinical testing SERAC1: BP4, BS1, BS2

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.